Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$101M |
| 2 |
PPL
PPL Corp
PPL
|
+$72.8M |
| 3 |
Occidental Petroleum
OXY
|
+$62.9M |
| 4 |
Duke Energy
DUK
|
+$61.4M |
| 5 |
FedEx
FDX
|
+$60M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$52.9M |
| 2 |
APA Corp
APA
|
+$51.1M |
| 3 |
Toro Company
TTC
|
+$34.3M |
| 4 |
CNH
CNH Industrial
CNH
|
+$32.6M |
| 5 |
Entergy
ETR
|
+$30.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 10.84% |
| 2 | Technology | 10.75% |
| 3 | Healthcare | 9.82% |
| 4 | Utilities | 8.33% |
| 5 | Energy | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Myriad Genetics
MYGN
$306M
| – | – |
-12,300
| Closed | -$178K |
|
2002
NBT Bancorp
NBTB
$2.71B
| – | – |
-22,909
| Closed | -$995K |
|
2003
Norwegian Cruise Line
NCLH
$7.92B
| – | – |
-23,670
| Closed | -$290K |
|
2004
Nordson
NDSN
$18.5B
| – | – |
-55,503
| Closed | -$13.2M |
|
2005
NeoGenomics
NEO
$2.18B
| – | – |
-12,691
| Closed | -$117K |
|
2006
New Fortress Energy
NFE
$78.5M
| – | – |
-360,000
| Closed | -$15.3M |
|
2007
Ingevity
NGVT
$2.42B
| – | – |
-25,350
| Closed | -$1.79M |
|
2008
National Health Investors
NHI
$3.6B
| – | – |
-11,187
| Closed | -$584K |
|
2009
NIO
NIO
$11.6B
| – | – |
-142,110
| Closed | -$1.39M |
|
2010
New Jersey Resources
NJR
$5.43B
| – | – |
-52,122
| Closed | -$2.59M |
|
2011
Nektar Therapeutics
NKTR
$2.53B
| – | – |
-32,833
| Closed | -$1.11M |
|
2012
Nelnet
NNI
$4.55B
| – | – |
-2,427
| Closed | -$220K |
|
2013
Nomad Foods
NOMD
$1.65B
| – | – |
-47,115
| Closed | -$812K |
|
|
NOTV
2014
DELISTED
Inotiv
NOTV
| – | – |
-74,855
| Closed | -$370K |
|
2015
ServiceNow
NOW
$133B
| – | – |
-161,850
| Closed | -$12.6M |
|
2016
Bank of N.T. Butterfield & Son
NTB
$2.3B
| – | – |
-13,509
| Closed | -$403K |
|
2017
Intellia Therapeutics
NTLA
$1.8B
| – | – |
-9,982
| Closed | -$348K |
|
2018
Nutrien
NTR
$35.9B
| – | – |
-106,717
| Closed | -$7.79M |
|
2019
Nuvation Bio
NUVB
$2.43B
| – | – |
-26,181
| Closed | -$50K |
|
|
NVMI
2020
Nova
NVMI
$12B
| – | – |
-6,803
| Closed | -$556K |
|
2021
NorthWestern Energy
NWE
$4.27B
| – | – |
-112,063
| Closed | -$6.65M |
|
2022
NatWest
NWG
$74B
| – | – |
-57,426
| Closed | -$371K |
|
2023
News Corp Class B
NWS
$18.7B
| – | – |
-27,609
| Closed | -$509K |
|
2024
News Corp Class A
NWSA
$16.4B
| – | – |
-1,675
| Closed | -$30K |
|
2025
Owens Corning
OC
$11.7B
| – | – |
-13,804
| Closed | -$1.18M |
|
Similar funds
Michael Gelband's Q1 2023 Portfolio in Review
As of Q1 2023, Michael Gelband held 2,250 positions worth $12.1B, up 75% from $6.89B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Michael Gelband deployed $5.01B of net new capital in Q1 2023, opening 668 new positions and adding to 659 existing holdings. Its largest new stake was Valero Energy: 333,288 shares worth $46.5M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 16% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $52.9M trimmed.
- Michael Gelband's largest Q1 2023 buy was Valero Energy: 333,288 shares worth $46.5M.
- Michael Gelband added most to Exelon in Q1 2023, an estimated $101M increase.
- Michael Gelband's biggest Q1 2023 reduction was Apple, cutting an estimated $52.9M.
- Michael Gelband fully exited APA Corp in Q1 2023, selling an estimated $51.1M.
- Michael Gelband's ten largest holdings make up 22% of its $12.1B portfolio in Q1 2023.
- Michael Gelband opened 668 new positions and closed 543 in Q1 2023.
- Michael Gelband's portfolio value rose 75% quarter-over-quarter to $12.1B.
Based on ExodusPoint Capital Management's 13F filing for Q1 2023, filed 11 May 2023.